Risk of metachronous peritoneal carcinomatosis
from colorectal cancer



1 year 2 years 3 years


  Colon cancer   Rectal cancer

  Age

  Primary site Left Right Transverse
  pT stage (colon) T0-T2 T3a/b T3c/d T4a T4b
  pT stage (rectal) T0-T2 T3 T4
  pN stage N0 N1 N2
  Radicality R0 R1 R2
  Type of surgery Elective Emergency
  Preoperative radiotherapy No Yes
  No. examined lymphnodes 12+ 0-11
  Adjuvant chemotherapy No Yes
  Mucinous tumour No Yes



Segelman J, Akre O, Gustafsson UO, Bottai M, Martling A. Individualized prediction of risk of metachronous peritoneal carcinomatosis from colorectal cancer. Colorectal Disease. 2014 May;16(5):359-67. doi: 10.1111/codi.12552

Segelman J, Akre O, Gustafsson UO, Bottai M, Martling A. External validation of models predicting the individual risk of metachronous peritoneal carcinomatosis from colon and rectal cancer. Colorectal Dis. 2016 Apr;18(4):378-85. doi: 10.1111/codi.13219.